Expression of HLA-DR, costimulatory molecules B7-1, B7-2, intercellular adhesion molecule-1 (ICAM-1) and Fas ligand (FasL) on gastric epithelial cells in Helicobacter pylori gastritis; influence of H. pylori eradication

Clinical and Experimental Immunology

Volumn 119, Issue 3, 2000, Pages 464-471

  Archimandritis, A ^a   Sougioultzis, S ^a   Foukas, P G ^a   Tzivras, M ^a   Davaris, P ^a   Moutsopoulos, H M ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Antigen presenting cell costimulatory molecules; Epithelial cell; FasL; Helicobacter pylori gastritis

Indexed keywords

AMOXICILLIN; B7 ANTIGEN; CD86 ANTIGEN; CLARITHROMYCIN; FAS ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LIGAND; OMEPRAZOLE;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENDOSCOPIC BIOPSY; ERADICATION THERAPY; FEMALE; GASTRITIS; GASTROINTESTINAL ENDOSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH EPITHELIUM;

EID: 0034117258     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01164.x     Document Type: Article

References (63)

1. 1 Dooley CP, Cochen H, Fitzgibbons PL, Bauer M, Appleman MD, Perez-Perez GI, Blaser MJ. Prevalence of Helicobacter pylori infection and histologie gastritis in asymptomatic persons. N Engl J Med 1989; 321:1562-6.
2. 2 Kuipers EJ, Thijs JC, Festen HP. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 1995; 9 (Suppl.):59-69.
3. 3 Parsonnet J, Friedman GD, VanderSteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325:1127-31.
4. 4 Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341:1359-62.
5. 5 Nomura A, Stemmermann GN, Chyou P, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma in a population of Japanese Americans in Hawaii. N Engl J Med 1991; 325:1132-6.
6. 6 Parsonnet J, Hansen S, Rodriguez L et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330:1267-71.
7. 7 Blaser MJ, Parsonnet J. Parasitism by the slow bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J Clin Invest 1994; 94:4-8.
8. 8 Archimandritis A, Bitsikas J, Tjivras M, Anastasakou E, Tsavaris N, Kalogeras D, Davaris P, Fertakis A. Non-cardia gastric adenocarcinoma and Helicobacter pylori infection. Ital J Gastroenterol 1993; 25:368-71.
9. 9 Van der Hulst RW, Rauws EA, Koycu B, Keller JJ, Bruno MJ, Tijssen JG, Tytgat GN. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology 1997; 113:1082-6.
10. 10 Archimandritis A, Balatsos V, Delis V, Manika Z, Skandalis N. Reappearance of H. pylori following eradication; implications on duodenal ulcer recurrence: a prospective 6 years study. J Clin Gastroenterol 1999; 28:345-7.
11. 11 Roggero E, Zucca E, Pinotti G et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995; 122:767-9.
12. 12 Chan WY, Hui PK, Chan JKC, Cheung PS, Ng CS, Sham CH, Gwi E. Epithelial damage by Helicobacter pylori in gastric ulcers. Histopathology 1991; 19:47-53.
13. 13 Hui PK, Chan WY, Cheung PS, Chan JK, Ng CS. Pathologic changes of gastric mucosa colonized by Helicobacter pylori. Hum Pathol 1992; 23:548-56.
14. 14 Smoot DT. How does Helicobacter pylori cause mucosal damage? Direct mechanisms. Gastroenterology 1997; 113 (Suppl.):S31-S34.
15. 15 Shimoyama T, Crabtree JE. Bacterial factors and immune pathogenesis in Helicobacter pylori infection. Gut 1998; 43 (Suppl.):S2-S5.
16. 16 Miller MJS, Correa P. Carcinogenesis, apoptosis and cell proliferation. Br Med Bull 1998; 54:151-62.
17. 17 Crabtree JE. The host inflammatory response to Helicobacter pylori. Eur J Gastroent Hepat 1998; 10 (Suppl. 1):S9-S13.
18. 18 Di Tommaso A, Xiang Z, Bugnoli M et al. Helicobacter pylori-specific CD4 + T-cell clones from peripheral blood and gastric biopsies. Infect Immun 1995; 63:1102-6.
19. 19 D'Elios MM, Manghetti M, De Carli M et al. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 1997; 158:962-7.
20. 20 D'Elios MM, Manghetti M, Almerigogna F et al. Different cytokine profile and antigen-specificity repertoire in Helicobacter pytori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur J Immunol 1997; 27:1751-5.
21. 21 Crabtree JE, Wyatt JI, Sobala GM, Miller G, Tompkins DS, Primrose JN, Morgan AG. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 1993; 34:1339-43.
22. 22 Schwarz RH. Costimulation of T lymphocytes: the role of CD28, CTLA-4 and B7/BB1 in interleukin-2 production and immunotherapy. Cell 1992; 71:1065-8.
23. 23 Reiser H, Stadecker MJ. Costimulatory B7 molecules in the pathogenesis of infectious and autoimmune diseases. N Engl J Med 1996; 335:1369-77.
24. 24 Van Seventer GA, Shimizu Y, Horgan KJ, Shaw S. The LFA-1 ligand ICAM-1 provides an important costimulatory signal for T cell receptor-mediated activation of resting T cells. J Immunol 1990; 144:4579-86.
25. 25 Abbas AK. Die and let live: eliminating dangerous lymphocytes. Cell 1996; 84:655-7.
26. 26 Strasser A. Death of a T cell. Nature 1995; 373:385-6.
27. 27 Andrew A, Wyatt JI, Dixon MF. Observer variation in the assessment of chronic gastritis according to the Sydney system. Histopathology 1994; 25:317-22.
28. 28 Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. Am J Surg Pathol 1996; 20:1161-81.
29. 29 Abbas AK, Lichtman AH, Pober JS. Cellular and molecular immunology, 3rd edn. Philadelphia: W.P. Saunders, 1997.
30. 30 Nickoloff BJ, Turka LA. Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes. Immunol Today 1994; 15:464-8.
31. 31 Mayer L, Shlien R. Evidence for function of Ia molecules on gut epithelial cells in man. J Exp Med 1987; 166:1471-83.
32. 32 Nickoloff BJ, Mitra RS, Green J, Zheng XG, Shimizu Y, Thompson C, Turka LA. Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-I/intercellular adhesion molecule-1 interaction. J Immunol 1993; 150:2148-59.
33. 33 Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983; ii:1115-9.
34. 34 Moutsopoulos HM, Hooks JJ, Chan CC, Dalamanga YA, Skopouli FN, Detrick B. HLA-DR expression by labial minor salivary gland tissues in Sjögren syndrome. Ann Rheum Dis 1986; 45:677-83.
35. 35 Papadimitriou CS, Ioachim-Velogianni EE, Tsianos EB, Moutsopoulos HM. Epithelial HLA-DR expression and lymphocyte subsets in gastric mucosa in type B chronic gastritis. Virch Arch A (Pathol Anat) 1988; 413:197-204.
36. 36 Gaspari AA, Jenkins MK, Katz SI. Class II MHC-bearing keratinocytes induce antigen specific unresponsiveness in hapten-specific TH1 clones. J Immunol 1988; 141:2216-20.
37. 37 Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14:233-58.
38. 38 Engstrand L, Scheynius A, Pahlson C. Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells. Infect Immun 1989; 57:827-32.
39. 39 El Kaissouni J, Bene MC, Faure GC. Activation of epithelial cells in gastritis. Digestion 1998; 59:53-59.
40. 40 Bamford KB, Fan X, Crowe SE et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell I phenotype. Gastroenterology 1998; 114:482-92.
41. 41 Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998; 66:5964-71.
42. 42 Lehmann FS, Stalder GA. Hypothesis on the role of cytokines in peptic ulcer disease. Eur J Clin Invest 1998; 28:511-9.
43. 43 Watanabe Y, Jacob CO. Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor-α on IFN-γ-induced HLA-DR and la expression depends on the maturation and differentiation stage of the cell. J Immunol 1991; 146:899-905.
44. 44 Manoussakis MN, Dimitriou ID, Kapsogeorgou EK, Xanthou G, Paikos S, Polihronis M, Moutsopoulos HM. Expression of B7 costimulatory molecules by salivary gland epithelial cells in patients with Sjögren's syndrome. Arthritis Rheum 1999; 42:229-39.
45. 45 Ye G, Barrera C, Fan XJ, Gourley WK, Crowe SE, Ernst PB, Reyes VE. Gastric epithelial cells express the costimulatory molecules B7-1 and B7-2 during infection with Helicobacter pylori and activate CD4 T cells. J Clin Invest 1997; 99:1628-38.
46. 46 Kuchroo VK, Das MP, Brown JA et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995; 80:707-18.
47. 47 Freeman GJ, Boussiotis VA, Anumanthan A et al. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 1995; 2:523-32.
48. 48 Diamond MS, Staunton DE, Marlin SD, Springer TA. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell 1991; 65:961-71.
49. 49 Scheynius A, Engstrand L. Gastric epithelial cells in Helicobacter pylori-associated gastritis express HLA-DR but not ICAM-1. Scand J Immunol 1991; 33:237-41.
50. 50 Engstrand L, Gustavsson S, Schwan A, Scheynius A. Local and systemic immune response in Helicobacter pylori-associated chronic gastritis before and after treatment. Scand J Gastroenterol 1993; 28:1105-11.
51. 51 Hatz RA, Rieder G, Stolte M, Bayerdörffer E, Meimarakis G, Schildberg F-W, Enders G. Pattern of adhesion molecule expression on vascular endothelium in Helicobacter pylori-associated antral gastritis. Gastroenterology 1997; 112:1908-19.
52. 52 Crowe SE, Alvarez L, Dytoc M et al. Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology 1995; 108:65-74.
53. 53 Bene L, Balázs M, Matkó J, Möst J, Dieich MP, Szöllösi J, Damjanovch S. Lateral organization of the ICAM-1 molecule at the surface of human lymphoblasts: a possible model for its codistribution with the IL-2 receptor, class I and class II HLA molecules. Eur J Immunol 1994; 24:2115-23.
54. 54 Miller J, Knorr R, Ferrone M, Houdei R, Carron CP, Dustin M. Intercellular adhesion molecule-1 dimerization and its consequences for adhesion mediated by lymphocyte function associated-1. J Exp Med 1995; 182:1231-41.
55. 55 Luksch CR, Winqvist O, Ozaki ME, Karlsson L, Jackson MR, Peterson PA, Webb SR. Intercellular adhesion molecule-1 inhibits interleukin 4 production by naive T cells. Proc Nat Acad Sci USA 1999; 96:3023-8.
56. 56 Nagata S, Golstein P. The fas death factor. Science 1995; 267:1449-55.
57. 57 Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270:1189-92.
58. 58 Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377:630-2.
59. 59 Giordano C, Stassi G, De Maria R et al. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997; 275:960-3.
60. 60 Polihronis M, Tapinos NI, Theocharis SE, Economou A, Kittas C, Moutsopoulos HM. Modes of epithelial cell death and repair in Sjögren's syndrome (SS). Clin Exp Immunol 1998; 114:485-90.
61. 61 O'Connell J, O'Sullivan GC, Collins JK, Shanahan F. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 1996; 184:1075-82.
62. 62 Bennett MW, O'Connell J, O'Sullivan GC, Roche D, Brady C, Kelly J, Collins JK, Shanahan F. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer. Gut 1999; 44:156-62.
63. 63 Van Parijs L, Abbas AK. Role of Fas-mediated cell death in the regulation of immune responses. Curr Opin Immunol 1996; 8:355-61.